XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information
12. SEGMENT INFORMATION

Information regarding industry segments at March 31, 2025 and 2024 and for the three months then ended are as follows (in millions):
Life
Science
Clinical
Diagnostics
Other
Operations
Net sales2025$228.6 $356.8 $— 
 2024$241.7 $368.6 $0.5 
Cost of goods sold
2025$100.2 $179.2 $— 
2024110.0 174.3 0.6 
Depreciation and amortization
2025$17.0 $21.1 $— 
202416.3 20.8 — 
Segment profit
2025$128.4 $177.6 $— 
 2024$131.7 $194.3 $(0.1)
Segment assets
2025$308.1 $482.0 $— 
2024291.7 491.7 — 

Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance. Our chief operating decision maker ("CODM") views Gross profit as the key driver in management's performance optimization strategy.

The following reconciles total segment gross profit to consolidated income before income taxes (in millions):
Three Months Ended
March 31,
 20252024
Total segment profit
$306.0 $325.9 
Selling, general and administrative expense
(208.8)(214.9)
Research and development expense
(73.5)(66.4)
Interest expense(12.0)(12.3)
Foreign currency exchange gains, net2.7 2.0 
Gains from change in fair market value of equity securities and loan receivable31.8 422.2 
Other income, net37.2 34.6 
Consolidated income before income taxes
$83.4 $491.1